What Changed
Price Move History
- Daily moves over 5%
- 93 152 sessions, October 22, 2025 to October 22, 2026
- Largest daily move
- +98% close of July 8, 2026
- 1-year change
- -67% closing prices, October 22, 2025 to October 22, 2026
- 1-month change
- -63.9% closing prices, September 22, 2026 to October 22, 2026
Company Description
RAFARMA PHARMA (WY) (OTC: RAFA) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $8.6M.
RAFA has declined 67.0% over the past year. The last closing price was $0.0140.
This page collects what Stock Titan holds for RAFA, including price data, latest news, and short interest trends.
Stock Performance
RAFARMA PHARMA (WY) (RAFA) closed at $0.0140 on October 22, 2026. Over the past 12 months, the price has lost 67.0%.
RAFA Metrics & Rankings
Price returns through October 22, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
RAFARMA PHARMA (WY) has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. View all RAFA news →
SEC Filings
Short Interest History
Short interest in RAFARMA PHARMA (WY) (RAFA) currently stands at 149 shares, representing 0.0% of the shares outstanding. Since November 2025, short interest has decreased by 79.1%.
Days to Cover History
Days to cover for RAFARMA PHARMA (WY) (RAFA) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
RAFA Company Profile & Sector Positioning
RAFARMA PHARMA (WY) (RAFA) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing RAFA often look at related companies in the same sector, including FULL ALLIANCE GROUP INC (FAGI), MEDICURE INC (MCUJF), NEXTLEAF SOLUTIONS LTD (OILFF), ONE WORLD PRODUCTS INC (OWPC), and CHRISTINA LAKE CANNABIS (CLCFF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate RAFA's relative position within its industry.